...
Redd: Thank you so much, Gabrielle, for giving me this opportunity.
SARS-CoV-2-specific CD8+ T cell responses in convalescent COVID-19 individuals, J Clin Invest, 2021 Mar 1; 131(5): e145476. doi: 10.1172/JCI145476.
Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population, J Clin Invest, 2020 Nov 2; 130(11): 6141-6150. doi: 10.1172/JCI142004.
Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers, J Clin Microbiol, 2021 Jan 21; 59(2): e02257-20. doi: 10.1128/JCM.02257-20. Print 2021 Jan 21.
Evaluation of Serological SARS-CoV-2 Lateral Flow Assays for Rapid Point-of-Care Testing, J Clin Microbiol, 2021 Jan 21; 59(2): e02020-20. doi: 10.1128/JCM.02020-20. Print 2021 Jan 21.
Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma, mBIO, 2021 Apr 20; 12(2): e00765-21. doi: 10.1128/mBio.00765-21.
Metabolic programs define dysfunctional immune responses in severe COVID-19 patients, Cell Rep, 2021 Mar 16; 34(11): 108863. doi: 10.1016/j.celrep.2021.108863. Epub 2021 Feb 26.
Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality, J Clin Inves, 2021 Apr 1; 131(7): e146927. doi: 10.1172/JCI146927.
Cytokine and Chemokine Levels in Coronavirus Disease 2019 Convalescent Plasma, Open Forum Infect Dis, 2020 Nov 26; 8(2): ofaa574. doi: 10.1093/ofid/ofaa574. eCollection 2021 Feb.
ABO blood group and SARS-CoV-2 antibody response in a convalescent donor population, Vox Sang, 2021 Aug; 116(7): 766-773. doi: 10.1111/vox.13070. Epub 2021 Jan 25.
Evaluation of Serological SARS-CoV-2 Lateral Flow Assays for Rapid Point-of-Care Testing, J Clin MIcrobiol, 2021 Jan 21; 59(2): e02020-20. doi: 10.1128/JCM.02020-20. Print 2021 Jan 21.